JP2007514773A5 - - Google Patents

Download PDF

Info

Publication number
JP2007514773A5
JP2007514773A5 JP2006545571A JP2006545571A JP2007514773A5 JP 2007514773 A5 JP2007514773 A5 JP 2007514773A5 JP 2006545571 A JP2006545571 A JP 2006545571A JP 2006545571 A JP2006545571 A JP 2006545571A JP 2007514773 A5 JP2007514773 A5 JP 2007514773A5
Authority
JP
Japan
Prior art keywords
alkyl
carbon atoms
carbons
independently
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006545571A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007514773A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/042897 external-priority patent/WO2005058798A2/en
Publication of JP2007514773A publication Critical patent/JP2007514773A/ja
Publication of JP2007514773A5 publication Critical patent/JP2007514773A5/ja
Pending legal-status Critical Current

Links

JP2006545571A 2003-12-17 2004-12-17 選択的シトクロムp450rai−1または選択的シトクロムp450rai−2阻害活性を有する化合物およびそれを得る方法 Pending JP2007514773A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53046203P 2003-12-17 2003-12-17
PCT/US2004/042897 WO2005058798A2 (en) 2003-12-17 2004-12-17 Compounds having selective cytochrome p450rai-1 or selective cytochrome p450rai-2 inhibitory activity and methods of obtaining the same

Publications (2)

Publication Number Publication Date
JP2007514773A JP2007514773A (ja) 2007-06-07
JP2007514773A5 true JP2007514773A5 (enExample) 2008-02-14

Family

ID=34700138

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006545571A Pending JP2007514773A (ja) 2003-12-17 2004-12-17 選択的シトクロムp450rai−1または選択的シトクロムp450rai−2阻害活性を有する化合物およびそれを得る方法

Country Status (6)

Country Link
US (2) US7226951B2 (enExample)
EP (1) EP1699775A2 (enExample)
JP (1) JP2007514773A (enExample)
CA (1) CA2550123A1 (enExample)
MX (1) MXPA06006819A (enExample)
WO (1) WO2005058798A2 (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007515433A (ja) * 2003-12-17 2007-06-14 アラーガン インコーポレイテッド Cyp26aおよびcyp26bの選択的阻害剤を使用するレチノイド反応性障害の処置方法
US7226951B2 (en) * 2003-12-17 2007-06-05 Allergan, Inc. Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same
JP2009108036A (ja) * 2007-09-28 2009-05-21 Fujifilm Corp 新規アセチレン化合物、その製造方法、それを構成単位として含むポリマー、該化合物及び/又は該ポリマーを含む組成物、該組成物を硬化させてなる硬化物
JP5302398B2 (ja) * 2008-08-15 2013-10-02 エフ.ホフマン−ラ ロシュ アーゲー 置換アミノテトラリン
ES2335849B1 (es) * 2008-10-03 2011-03-22 Consejo Superior De Investigaciones Cientificas (Csic) Derivados de cromano y sus usos como inhibidores de la actividad de las proteinas desacoplantes.
KR101322496B1 (ko) * 2008-11-17 2013-10-29 에프. 호프만-라 로슈 아게 나프틸아세트산
WO2010055005A1 (en) * 2008-11-17 2010-05-20 F. Hoffmann-La Roche Ag Naphthylacetic acids
US8188090B2 (en) * 2008-11-17 2012-05-29 Hoffman-La Roche Inc. Naphthylacetic acids
CA2848540A1 (en) 2011-09-15 2013-03-21 Arizona Board Of Regents, A Body Corporate Of The State Of Arizona Acting For And On Behalf Of Arizona State University Therapeutic compounds
US8470884B2 (en) 2011-11-09 2013-06-25 Hoffmann-La Roche Inc. Alkenyl naphthylacetic acids
US9000044B2 (en) 2012-02-28 2015-04-07 Hoffmann-La Roche Inc. Substituted naphthylacetic acids
TWI633087B (zh) 2012-06-13 2018-08-21 赫孚孟拉羅股份公司 新穎二氮雜螺環烷及氮雜螺環烷
RS59512B1 (sr) 2012-09-25 2019-12-31 Hoffmann La Roche Derivati heksahidropirolo[3,4−c]pirola i srodna jedinjenja kao inhibitori autotaksina (atx) i kao inhibitori proizvodnje lizofosfatidne kiseline (lpa) za lečenje npr. bubrežnih bolesti
AR095079A1 (es) 2013-03-12 2015-09-16 Hoffmann La Roche Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo
WO2015078803A1 (en) 2013-11-26 2015-06-04 F. Hoffmann-La Roche Ag NEW OCTAHYDRO-CYCLOBUTA [1,2-c;3,4-c']DIPYRROL-2-YL
US10328040B2 (en) 2014-01-17 2019-06-25 Arizona Board Of Regents On Behalf Of Arizona State University Therapeutic methods
CN106103446B (zh) 2014-03-26 2019-07-30 豪夫迈·罗氏有限公司 作为自分泌运动因子(atx)和溶血磷脂酸(lpa)生产抑制剂的二环化合物
KR20160128428A (ko) 2014-03-26 2016-11-07 에프. 호프만-라 로슈 아게 오토탁신(atx) 및 리소포스파티드산(lpa) 생성 억제제로서의 축합형 [1,4]다이아제핀 화합물
TWI653227B (zh) * 2014-07-11 2019-03-11 美商陶氏農業科學公司 用於製備4-(1-(4-(全氟乙氧基)苯基)-1h-1,2,4-三唑-3-基)苯甲醯疊氮化物之改良方法
MA41898A (fr) 2015-04-10 2018-02-13 Hoffmann La Roche Dérivés de quinazolinone bicyclique
CN105481723B (zh) * 2015-04-29 2017-08-25 中国农业大学 一种非均相催化的烷基/苄基/芳基脲类化合物的制备方法
CN108026077B (zh) 2015-09-04 2021-11-05 豪夫迈·罗氏有限公司 苯氧基甲基衍生物
KR20180054635A (ko) 2015-09-24 2018-05-24 에프. 호프만-라 로슈 아게 오토탁신(atx) 억제제로서 이환형 화합물
CR20180143A (es) 2015-09-24 2018-05-03 Hoffmann La Roche Nuevos compuestos biciclicos como inhibidores duales de atx/ca
EP3353178B1 (en) 2015-09-24 2021-07-14 F. Hoffmann-La Roche AG Bicyclic compounds as dual atx/ca inhibitors
PE20180461A1 (es) 2015-09-24 2018-03-06 Hoffmann La Roche Nuevos compuestos biciclicos como inhibidores de la atx
CA3013411A1 (en) * 2016-02-03 2017-08-10 Galderma Research & Development Novel biaromatic propynyl compounds, pharmaceutical and cosmetic compositions containing same, and uses thereof
US10238626B2 (en) 2017-01-23 2019-03-26 Arizona Board Of Regents On Behalf Of Arizona State University Therapeutic compounds
US10231947B2 (en) 2017-01-23 2019-03-19 Arizona Board Of Regents On Behalf Of Arizona State University Isochroman compounds and methods of use thereof
US10238655B2 (en) 2017-01-23 2019-03-26 Arizona Board Of Regents On Behalf Of Arizona State University Dihydroindene and tetrahydronaphthalene compounds
RU2019132254A (ru) 2017-03-16 2021-04-16 Ф. Хоффманн-Ля Рош Аг Гетероциклические соединения, пригодные в качестве дуальных ингибиторов atx/ca
CN110382484B (zh) 2017-03-16 2022-12-06 豪夫迈·罗氏有限公司 新的作为atx抑制剂的二环化合物

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3699149A (en) 1968-10-14 1972-10-17 Daiichi Seiyaku Co Phenyl esters of t-amcha
US4326055A (en) * 1977-12-22 1982-04-20 Hoffmann-La Roche Inc. Stilbene derivatives
DK159967C (da) * 1977-12-22 1991-06-03 Hoffmann La Roche Analogifremgangsmaade til fremstilling af terapeutisk aktive stilbenderivater
JPS58121242A (ja) * 1982-01-11 1983-07-19 Mitsubishi Petrochem Co Ltd トラン−4−酢酸誘導体及びトラン−4−酢酸誘導体を有効成分とする抗炎症剤
US5202471A (en) * 1990-02-06 1993-04-13 Allergan, Inc. Alkyl, alkoxy and thioalkoxy substituted diphenyl acetylenes having retinoid like activity
US5599967A (en) * 1994-12-29 1997-02-04 Allergan Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl of heteroaryl group having retinoid-like biological activity
EP0800517A1 (en) * 1994-12-29 1997-10-15 Allergan Acetylenes disubstituted with a 5 or 8 substituted tetrahydronaphthyl or dihydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activity
US5952345A (en) * 1995-09-01 1999-09-14 Allergan Sales, Inc. Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
US5675024A (en) * 1995-11-22 1997-10-07 Allergan Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4,-tetrahydroquinoline carboxylic acids, having an electron withdrawing substituent in the aromatic or heteroaromatic moiety, having retinoid-like biological activity
US5723666A (en) * 1996-06-21 1998-03-03 Allergan Oxime substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
US6313168B1 (en) * 1999-12-15 2001-11-06 Allergan Sales, Inc. Use of retinoid receptor antagonists in the treatment of cartilage and bone pathologies
US6313107B1 (en) * 2000-08-29 2001-11-06 Allergan Sales, Inc. Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI
US6252090B1 (en) * 2000-08-29 2001-06-26 Allergan Sales, Inc. Compounds having activity as inhibitors of cytochrome P450RAI
US6387951B1 (en) * 2000-08-29 2002-05-14 Allergan Sales, Inc. Compounds having activity as inhibitors of cytochrome P450RAI
US6369225B1 (en) * 2000-08-29 2002-04-09 Allergan Sales, Inc. Compounds having activity as inhibitors of cytochrome P450RAI
US6369261B1 (en) * 2000-08-29 2002-04-09 Allergan Sales, Inc. Compounds having activity as inhibitors of cytochrome P450RAI
US6303785B1 (en) * 2000-08-29 2001-10-16 Allergan Sales, Inc. Compounds having activity as inhibitors of cytochrome P450RAI
US6380256B1 (en) * 2000-08-29 2002-04-30 Allergan Sales, Inc. Compounds having activity as inhibitors of cytochrome P450RAI
US6291677B1 (en) * 2000-08-29 2001-09-18 Allergan Sales, Inc. Compounds having activity as inhibitors of cytochrome P450RAI
AU2001286471B2 (en) * 2000-08-29 2006-09-07 Allergan, Inc. Compounds having activity as inhibitors of cytochrome P450RAI
US7226951B2 (en) * 2003-12-17 2007-06-05 Allergan, Inc. Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same

Similar Documents

Publication Publication Date Title
JP2007514773A5 (enExample)
JP2009529540A5 (enExample)
JP2018115201A5 (enExample)
JP2007508359A5 (enExample)
JP2012092103A5 (enExample)
JP2013532660A5 (enExample)
JP2019094345A5 (enExample)
JP2010532768A5 (enExample)
JP2006528685A5 (enExample)
JP2006528621A5 (enExample)
JP2007519618A5 (enExample)
JP2013539789A5 (enExample)
JP2009507896A5 (enExample)
JP2006527776A5 (enExample)
JP2016530259A5 (enExample)
JP2016056183A5 (enExample)
JP2015522650A5 (enExample)
JP2015524019A5 (enExample)
JP2007508362A5 (enExample)
JP2018533593A5 (enExample)
JP2010510232A5 (enExample)
CN113906026A (zh) 作为atr激酶抑制剂的2,4,6-三取代的嘧啶化合物
JP2007517037A5 (enExample)
JP2005535594A5 (enExample)
JP2010535706A5 (enExample)